Abbott Stock Drops 4.18% to $97 Despite Q1 Beat as Cancer Diagnostics and Devices Drive Revenue
Abbott Laboratories (NYSE: ABT) stock dropped 4.18% to around $97 on Thursday even after the healthcare giant posted a first-quarter earnings beat, reporting adjusted profit of $1.15 per share against…






